CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$6.46M |
| 3 |
Gilead Sciences
GILD
|
+$6.38M |
| 4 |
Amgen
AMGN
|
+$6.24M |
| 5 |
Adobe
ADBE
|
+$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$5.18M |
| 2 |
Analog Devices
ADI
|
+$3.75M |
| 3 |
Amazon
AMZN
|
+$3.48M |
| 4 |
lululemon athletica
LULU
|
+$3.4M |
| 5 |
iQIYI
IQ
|
+$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Mirum Pharmaceuticals
MIRM
$3.89B
| $159K | 0.03% |
5,394
+4,408
| +447% | +$130K |
|
227
Zai Lab
ZLAB
$3.49B
| $159K | 0.03% |
5,802
+4,431
| +323% | +$121K |
|
228
Mercado Libre
MELI
$119B
| $157K | 0.03% |
100
-87
| -47% | -$137K |
|
229
Relay Therapeutics
RLAY
$700M
| $157K | 0.03% |
14,257
+11,122
| +355% | +$122K |
|
230
Scholar Rock
SRRK
$3.04B
| $157K | 0.03% |
8,346
+6,905
| +479% | +$130K |
|
231
Vir Biotechnology
VIR
$721M
| $157K | 0.03% |
15,560
+12,112
| +351% | +$122K |
|
232
Apogee Therapeutics
APGE
$2.29B
| $155K | 0.03% |
+5,555
| New | +$155K |
|
233
Genmab
GMAB
$16.9B
| $154K | 0.03% |
4,845
+3,770
| +351% | +$120K |
|
234
Protagonist Therapeutics
PTGX
$3.5B
| $153K | 0.03% |
6,675
+5,202
| +353% | +$119K |
|
235
Akero Therapeutics
AKRO
$3.57B
| $151K | 0.03% |
6,449
+5,023
| +352% | +$117K |
|
|
SAGE
236
DELISTED
Sage Therapeutics
SAGE
| $150K | 0.03% |
6,937
+5,406
| +353% | +$117K |
|
|
DCPH
237
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $150K | 0.03% |
9,272
+7,246
| +358% | +$117K |
|
238
Xencor
XNCR
$600M
| $149K | 0.03% |
7,041
+5,493
| +355% | +$117K |
|
239
Aurinia Pharmaceuticals
AUPH
$1.62B
| $149K | 0.03% |
16,613
+12,940
| +352% | +$116K |
|
240
Veeva Systems
VEEV
$46.3B
| $148K | 0.03% |
771
-7,497
| -91% | -$1.44M |
|
241
Day One Biopharmaceuticals
DAWN
$773M
| $147K | 0.03% |
10,067
+7,841
| +352% | +$114K |
|
242
Cadence Design Systems
CDNS
$98.3B
| $147K | 0.03% |
538
-475
| -47% | -$129K |
|
|
AVDL
243
Avadel Pharmaceuticals
AVDL
$1.49B
| $146K | 0.03% |
10,327
+8,029
| +349% | +$113K |
|
244
Agios Pharmaceuticals
AGIO
$2.12B
| $144K | 0.03% |
6,469
+5,040
| +353% | +$112K |
|
245
Ligand Pharmaceuticals
LGND
$3.23B
| $144K | 0.03% |
2,012
+1,571
| +356% | +$112K |
|
246
BioCryst Pharmaceuticals
BCRX
$1.72B
| $142K | 0.03% |
23,692
+18,827
| +387% | +$113K |
|
247
Keros Therapeutics
KROS
$628M
| $138K | 0.03% |
3,460
+2,702
| +356% | +$107K |
|
248
CSX Corp
CSX
$60.5B
| $137K | 0.03% |
3,939
-3,537
| -47% | -$123K |
|
249
Geron
GERN
$874M
| $133K | 0.03% |
62,820
+49,394
| +368% | +$104K |
|
250
Marriott International Class A Common Stock
MAR
$72.8B
| $131K | 0.03% |
583
-528
| -48% | -$119K |
|